EP0543942B1 — Homogeneous assay system
Assigned to F Hoffmann La Roche AG · Expires 2001-01-24 · 25y expired
What this patent protects
A process for discriminating sequence variants of a target nucleic acid is described. In this process variant specific cleavage products of a labeled oligonucleotide probe are produced by the 5'-3' exonuclease activity of a template dependent nucleic acid polymerase, which allows…
USPTO Abstract
A process for discriminating sequence variants of a target nucleic acid is described. In this process variant specific cleavage products of a labeled oligonucleotide probe are produced by the 5'-3' exonuclease activity of a template dependent nucleic acid polymerase, which allows to identify the sequence variants present in a sample.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.